Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Anticancer Research|December 25, 2009
Changes in UNC5C gene methylation during human gastric carcinogenesisKenji Hibi, Makiko Sakata, Kazuma Sakuraba, et al.Anticancer Research|August 5, 2010
Methylation of the p16 gene is frequently detected in lymphatic-invasive gastric cancerTetsuhiro Goto, Hiroki Mizukami, Atsushi Shirahata, et al.Anticancer Research|February 13, 2010
Methylation of the DCC gene is lost in advanced gastric cancerKenji Hibi, Makiko Sakata, Kazuma Sakuraba, et al.Anticancer Research|June 10, 2010
Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancerKenji Hibi, Tetsuhiro Goto, Yo-Hei Kitamura, et al.Investigational New Drugs|May 5, 2015
A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 studyNorisuke Nakayama, Atsushi Sato, Soichi Tanaka, et al.Anticancer Research|October 23, 2009
Down-regulation of Tip60 gene as a potential marker for the malignancy of colorectal cancerKazuma Sakuraba, Takashi Yasuda, Makiko Sakata, et al.Hepato-Gastroenterology|November 27, 2012
Methylation of the WNT5A gene is frequently detected in early gastric carcinomaKenji Hibi, Makiko Sakata, Kazuaki Yokomizi, et al.Anticancer Research|January 2, 2010
Methylation of the MGMT gene is frequently detected in advanced gastric carcinomaKenji Hibi, Makiko Sakata, Kazuaki Yokomizo, et al.Anticancer Research|April 12, 2012
Methylation of the DFNA5 gene is frequently detected in colorectal cancerKazuaki Yokomizo, Yoshikuni Harada, Kazuhiro Kijima, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 19, 2013
[Efficacy and safety of cetuximab+irinotecan for unresectable advanced or recurrent colorectal cancer]Hitoshi Soda, Hiroshi Nemoto, Sotaro Akatsuka, et al.Pageof 12